Two Medtronic Pumps Recalled

February 1, 2013
Medtronic is advising customers not to use unapproved drugs with SynchroMed infusion pumps distributed between April 1999 and November 2012, due to a heightened rate of adverse events. Drugs not designated specifically for use with the SynchroMed II and SynchroMed EL implantable pumps can lead to a 7 percent failure rate after 78 months, the voluntary Class I recall notice states. The failures may cause the pumps’ motor to temporarily or permanently stall, interrupting infusion.
The GMP Letter